Subject to applicable law, the purposes for which we use and process Personal Data, and the legal basis for such processing, are set forth below. Our innovative approach integrates foundational science with a defined clinical biomarker to deliver a new class of monotherapies for patients who will not benefit from PD-1/L1 inhibitors. For more information, go to. It is committed to developing tumor cellular immunotherapeutics through its own innovative technology platforms. life. or be The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments. 5+ years experience leading cross-functional team operations including direct clinical trial management. Jan 10, 2023. www.precisiononcologynews.com . Bayer is an innovation company with a more than 150-year history. "La investigacin de NextPoint Therapeutics proporciona una comprensin profunda de un mecanismo novedoso, la va Hhla2, que apaga el sistema inmunitario en los tumores; nuestro objetivo es desarrollar nuevos tratamientos para pacientes con cncer", segn explica Biniszkiewicz, director ejecutivo de NextPoint Therapeutics. Bayer is committed to driving sustainable development and generating a positive impact with its businesses. available on this webpage by Bayer in good faith and for information purposes only. Deforestation and Forest Degradation, Postion If you breach any provision of these Terms, any license you have obtained will be automatically rescinded and terminated. The investment portfolio includes more than 50 companies. The support of our new investors along with the continued commitment of our existing investors and founders emphasizes our momentum and progress in defining precision immuno-oncology for new patient segments., Juergen Eckhardt, MD, Head of Leaps by Bayer, commented, Leaps by Bayer was founded to help solve ten of the worlds biggest challenges in health and agriculture, including preventing and curing cancer. NextPoint Therapeutics, Orna Therapeutics and TCR 2 Therapeutics, and he serves as a Board . The tender offer referenced herein is not being made, directly or indirectly, in or into the United on These factors include those discussed in Bayers public reports which are available on the Bayer website at www.bayer.com. We do not knowingly collect information from minors under the age of 13 years without parental consent. R&D expenses before special items amounted to 5.3 billion euros. NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today the appointment of Leena Gandhi, MD, PhD, as Chief Medical Officer (CMO).. As CMO, Dr. Gandhi will oversee the clinical development of NextPoint's precision immuno-oncology programs that target the newly discovered HHLA2 pathway to activate anti-tumor immune responses. Bhatt RS, Berjis A, Konge JC, et al. For more information, go to leaps.bayer.com. At the same time, the Group aims to increase its earning power and create value through innovation and growth. (888) 929-NEXT 4043 N Ravenswood Ave, #317, Chicago, 60613 hello@nextpoint.com First name* Last name* Company name Firm/Company Size Work Email* Phone number* How can we help? for Its products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. NextPoint Therapeutics, Inc. (NextPoint, we, us or our) has created a website at https://www.nextpointtx.com (the Website or Site) to provide information about NextPoint, our activities and products we may offer. Alternatively, users can deactivate cookies from third-party providers by going to the network advertising initiatives deactivation page (link:https://optout.networkadvertising.org/?c=1). combating counterfeits, Bayer CapSeal Please note that if you do not provide consent, if you withdraw your consent or object to processing, or if you choose not to provide certain Personal Data, we may be unable to provide you some or all of the Site. Describe your request with sufficient detail that allows us to properly understand, evaluate, and respond to it. The final prospectus, when published, will be available on the website of NextPoint Therapeutics, founded and funded by MPM Capital, has assembled a team of proven drug developers to build a broad strategic pipeline of first-in-class #immunotherapies based on a novel,. Australia, Canada, South Africa or Japan or any other jurisdiction, where access to the materials is Lanka, Taiwan, Our Site may use the following technologies to implement cookies and pixels: If you do not wish to receive any interest-based advertising, you can deactivate Googles use of cookies for these purposes by going tohttps://www.google.com/settings/ads. We are currently looking to add an Associate Director or Director, Clinical Operations to our fast moving, roll-up your sleeves team environment. NextPoint Therapeutics Announces $80 Million Series B Financing co-led by Leaps by Bayer and Sanofi Ventures to Advance Novel Immuno-Oncology Programs, LabCentral, 238 Main Street, 5th Floor, Cambridge, MA 02142. for a hungry planet, Bayer Published Jan. 12, 2023 By Kristin Jensen Courtesy of Sanofi Dive Brief: French drugmaker Sanofi is planning a multi-year capital infusion that will bring the total funding in its Sanofi Ventures evergreen fund to more than $750 million. Cambridge, MA / Leverkusen, Germany January 10, 2023 NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today that it raised $80 million in Series B financing co-led by Leaps by Bayer, the impact investment arm of Bayer AG, and Sanofi Ventures, the strategic venture capital arm for Sanofi. Bayer is committed to driving sustainable development and generating a positive impact with its businesses. Neither this announcement nor anything contained Distances, Work We provide these links merely for your convenience. NextPoint is building a deep understanding of the HHLA2 tumor-specific immune-escape mechanism, with the ultimate goal of establishing standalone treatments in cancers with high HHLA2 expression, said Detlev Biniszkiewicz, PhD, Chief Executive Officer of NextPoint Therapeutics. Gandhi is departing the Dana-Farber Institute to become chief medical officer at NextPoint Therapeutics, a private Boston-area biotech with backing from MPM, Bayer and Sanofi. Viewing the materials you seek to access may not be lawful in certain jurisdictions. Infringe any third partys copyright, patent, trademark, trade secret or other proprietary rights or rights of publicity or privacy. Pharmacists, Kong, China, Ireland, Career, Your By clicking on the I AGREE button, I certify that I am not located in the United States, NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today that it raised $80 million in Series B financing co-led by Leaps by Bayer, the . Statements, Reports access to the materials is prohibited or restricted. We will never disclose your PII to third parties for direct marketing purposes without your authorization. & LEVERKUSEN, Germany, January 10, 2023--NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today that it raised $80. If you would like to stop receiving newsletters or other marketing or promotional messages, notifications, or updates, you may do so by following the unsubscribe instructions that appear in these e-mail communications. Our team of . To analyze and improve our Services, administer our Site and Services, provide you with access to our Services, analyze and improve our information technology, monitor compliance with our Terms of Use, and enforce our Terms of Use or other legal or regulatory obligations, Geolocation Data such as physical location information that may be provided by the device you are using. The Bayer brand stands for trust, reliability and quality throughout the world. Stewardship, Pharmaceuticals To exercise your rights, you may contact us as at. Procurement Management Trainee Program, Bridging prohibited or restricted. Phone: Sterling National Bank is providing $2.5 million in a senior facility, and Bigfoot Capital is providing $2.0m in mezzanine financing. Presentations, Annual New Talent, Bayer 04 archive, Shareholder Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. Find out more: www.sanofiventures.com, Kira PeikoffLeaps by Bayer1(973)791-3348kira.peikoff@bayer.com. or the solicitation of an offer to buy or subscribe for, any securities. circumstances, constitute a public offering or an invitation to the public in connection with any To protect your privacy and security, we may take steps to verify your identity in order to respond to your request. Agriculture, Recognize & Authority, United Arab NextPoint is developing medications targeting this novel axis to expand the benefit of immunotherapies to more cancer patients. For example, you will not use the Website to violate any law, statute or regulation (including, without limitation, those governing export control, consumer protection, unfair competition, anti-discrimination or false advertising). Freemans and Zangs independent discovery and characterization of the HHLA2 pathway formed the basis of the NextPoint approach. Supply Chain Management Trainee Program, International NEXTPOINT THERAPEUTICS, INC. Company Number 7059407 Incorporation Date 17 September 2018 (over 4 years ago) Company Type Corporation Jurisdiction Delaware (US) Agent Name THE CORPORATION TRUST COMPANY Agent Address CORPORATION TRUST CENTER 1209 ORANGE ST, WILMINGTON, New Castle, DE, 19801 Directors / Officers THE CORPORATION TRUST COMPANY, agent Meeting & Agenda, Stockholders' You can use our locations menu to Kaiser-Wilhelm-Allee 1 About. shall form the basis of, or be relied upon in connection with, any offer or commitment And here is our regular feature in which we highlight a different person each week. Effective Date. in any other circumstances falling within Article 3(2) of the Prospectus Directive. This area provides news, videos and publications, as well as overviews of social Media channels and mobile apps of the Bayer Group. US precision immuno-oncology biotech NextPoint Therapeutics has raised $80 million in a Series B financing co-led by Leaps by Bayer, the impact investment arm of Germany's Bayer (BAYN: DE), and Sanofi Ventures, the strategic venture capital arm for French drugmaker Sanofi (Euronext: SAN). investment decision regarding the securities referred to herein should only be made on the basis Bayer, Research and The Bayer brand stands for trust, reliability and quality throughout the world. available in electronic format on this webpage does not constitute an offer to sell or the the Statement, Cookie Sci Immunol. While immune checkpoint inhibitors targeting PD-1/L1 have revolutionized cancer treatments, many patients do not benefit from these medications and require novel therapeutic strategies. NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today the appointment of Leena Gandhi, MD, PhD, as Chief Medical Officer (CMO).. As CMO, Dr. Gandhi will oversee the clinical development of NextPoint's precision immuno-oncology programs that target the newly discovered HHLA2 pathway to activate anti-tumor immune responses. Regulations, Sustainable on Provide sufficient information that allows us to reasonably verify you are the person about whom we collected personal information or an authorized representative. Where we are processing your Personal Data, subject to applicable law, you also have the right to: To exercise your rights, you may contact us as atinfo@nextpointtx.com. You are currently on the Bayer global Drs. NextPoint Therapeutics, Inc. Street Address 1 Street Address 2; 238 MAIN STREET: City State/Province/Country ZIP/PostalCode Phone Number of Issuer; CAMBRIDGE: MASSACHUSETTS: 02142: 5082041115: 3. 2021 Jul 9;6(61):9792. In most cases, we need to process certain components of your Personal Data in order to fulfill our contractual obligations to you and for our legitimate interests. We do not accept any responsibility or liability for these policies and procedures. NextPoint originated from the combined expertise of its academic founders, Gordon Freeman, PhD, of the Dana-Farber Cancer Institute, and XingXing Zang, PhD, of Albert Einstein College of Medicine. Read more about our economic, ecological and social challenges and opportunities. Access to electronic versions of these materials is being made available on this webpage by Bayer in We encourage you to review this Privacy Notice often to stay informed of how we may process your information. us, How Archive, Quarterly Angela Poppe Ries, MD, was named chief medical officer of VyncaCare, a home healthcare company for patients living with serious illness. announcements and other documents available in electronic format on this webpage does not constitute Our innovative approach integrates foundational. Our innovative approach integrates foundational science with a defined clinical biomarker to deliver a new class of monotherapies for patients who will not benefit from PD-1/L1 inhibitors. Disseminate materials that impact or invade the privacy of others, such as photographs, video clips, sound recordings, personally identifiable information, or other materials that reveal personal, private or sensitive information about another person, without that persons consent. Personal Information does not include publicly available information, information that is de-identified, aggregated information, or any other information outside the scope of the California Consumer Privacy Act of 2018 (CCPA). Expression, clinical significance, and receptor identification of the newest B7 family member HHLA2 protein. Governance, Sustainability
Parking Near Hyatt Regency Waikiki,
Booking Office Aneurin Bevan,
Articles N